在食道状细胞癌中CD-NTase酶的临床和功能表征

Zhiwen Gong1,2, Hongcheng Zhong1, Shijiancong Liu1

  • 1Department of Thoracic Surgery, The Fifth Affiliated Hospital, Sun Yat-sen Unversity, Zhuhai 519000, China.

Journal of Cancer
|July 14, 2025
PubMed
概括

MB21D2是食道状细胞癌 (ESCC) 的关键预后因素. 低MB21D2表达恶化了存活率并促进了瘤的进展,将其确定为ESCC的潜在治疗标.